Psychiatric Medicine Associates, Llc

Skokie, Illinois 60076

4 studies enrolling now · 18 studies all time

What they study most

Anhedonia, Bipolar Disorder, Depression, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Major Depressive Disorder, Normative, Treatment Resistant Depression

Studies at this site

• A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression — Recruiting now
• "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" — Recruiting now
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression — Recruiting now
• Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) — Enrolling by invitation
• A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure — Stopped early
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) — Stopped early
• A Study of JNJ-55308942 in the Treatment of Bipolar Depression — Completed
• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression — Completed
• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression — Completed
• The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes — Stopped early
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression — Stopped early
• Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials — Completed
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression — Completed
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females — Completed
• Study of NSI-189 for Major Depressive Disorder — Status unconfirmed
• Treatment-Resistant Depression Registry — Completed